Competition Law Newsletter – May 2024
- Under Category:
- Competition Law
- Knowledge Center
The month of May 2024 witnessed several updates on the competition law front with orders by the Delhi High Court, the NCLAT, and several by the CCI on enforcement and combinations.
We bring to you all the updates through this edition of the Competition Law Newsletter:
Delhi High Court
- Delhi High Court’s order clarifying that the interest on penalty shall be calculated only on issuance of demand notice.
National Company Law Appellate Tribunal
- NCLAT dismisses the appeal filed by Sundaram Brakes.
Competition Commission of India
- CCI approves Nirma’s acquisition of Glenmark Life Sciences;
- CCI approves TPG-GIC investment in Asian Institute of Nephrology and Urology Private Limited;
- CCI approves minority investment in Shadowfax by TPG;
- CCI approves acquisition of certain stake in Pricol by Minda;
- CCI approves acquisition of Tianish Labs by Matrix Pharma and Kotak;
- CCI dismisses allegation of abuse against Senior Citizens’ Apartment Developer in Bangalore; and
- CCI dismisses allegation of abusive conduct levied against WordPress.
We hope this is helpful. Please feel free to revert in case of any clarification.
______________________________________________________________________________
Disclaimer: The content provided in this newsletter is for informational purposes only and does not constitute legal advice.
Join our community on LinkedIn. Click Here
